1999
DOI: 10.1097/00005392-199904010-00845
|View full text |Cite
|
Sign up to set email alerts
|

The Expression of Hslo Transcript Is Largely Locally Restricted Following Intracavernous Injection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2001
2001
2001
2001

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Another approach to treatment of erectile insufficiency due to neuropathy may involve the use of K ϩ channels somatic gene (naked pcDNA/hSLo cDNA) inoculation into the corporeal tissue. Such a possibility is suggested by experiments in which a single intracorporeal injection of this gene restored the streptozotocin-induced decline in erectile capacity in rats in vivo (423), and in which the expression of the transcript was largely confined to the original tissue of injection (the penis) at time points greater than 24 h after inoculation (424). Moreover, the isolation of prostaglandin receptors EP2, EP3I, EP3II, and TP (425) and the isolation of caveolin-1 and caveolin-3 (inhibitors of NOS activity) (426) in the human corporeal tissue may help in designing new therapeutic approaches for management of erectile insufficiency and priapism, respectively.…”
Section: Tissue and Molecular Engineering In Treatment Of Erectile Dymentioning
confidence: 99%
“…Another approach to treatment of erectile insufficiency due to neuropathy may involve the use of K ϩ channels somatic gene (naked pcDNA/hSLo cDNA) inoculation into the corporeal tissue. Such a possibility is suggested by experiments in which a single intracorporeal injection of this gene restored the streptozotocin-induced decline in erectile capacity in rats in vivo (423), and in which the expression of the transcript was largely confined to the original tissue of injection (the penis) at time points greater than 24 h after inoculation (424). Moreover, the isolation of prostaglandin receptors EP2, EP3I, EP3II, and TP (425) and the isolation of caveolin-1 and caveolin-3 (inhibitors of NOS activity) (426) in the human corporeal tissue may help in designing new therapeutic approaches for management of erectile insufficiency and priapism, respectively.…”
Section: Tissue and Molecular Engineering In Treatment Of Erectile Dymentioning
confidence: 99%